サンプルお申込み

お問い合わせ

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、ブプレノルフィン経皮吸収型パッチの世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にブプレノルフィン経皮吸収型パッチ市場を分類しています。
本レポートでは世界のブプレノルフィン経皮吸収型パッチ市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Grunenthal、PurduePharma、Luye Pharma

レポートはブプレノルフィン経皮吸収型パッチの主要生産者を調査し、主要地域や国の消費状況も提供します。ブプレノルフィン経皮吸収型パッチの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    5mcg/h
    7.5mcg/h
    10mcg/h
    15 mcg/h
    20 mcg/h

用途別の市場セグメント：
    Relieve Cancer Pain
    Other

本レポートの詳細内容
本レポートは、世界のブプレノルフィン経皮吸収型パッチ市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてブプレノルフィン経皮吸収型パッチ市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）のブプレノルフィン経皮吸収型パッチ生産量、成長率、市場シェアを調査している。

二. 消費面では、ブプレノルフィン経皮吸収型パッチの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーのブプレノルフィン経皮吸収型パッチ売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のブプレノルフィン経皮吸収型パッチ市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本ブプレノルフィン経皮吸収型パッチのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：ブプレノルフィン経皮吸収型パッチのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： ブプレノルフィン経皮吸収型パッチの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおけるブプレノルフィン経皮吸収型パッチの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章ブプレノルフィン経皮吸収型パッチメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：ブプレノルフィン経皮吸収型パッチの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：ブプレノルフィン経皮吸収型パッチの主要メーカーの概要を提供し、製品の説明と仕様、ブプレノルフィン経皮吸収型パッチの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：ブプレノルフィン経皮吸収型パッチの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

The global Buprenorphine Transdermal Patches market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Buprenorphine Transdermal Patches is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Buprenorphine Transdermal Patches is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Buprenorphine Transdermal Patches is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Buprenorphine Transdermal Patches include Grunenthal, PurduePharma and Luye Pharma, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Buprenorphine Transdermal Patches, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Buprenorphine Transdermal Patches, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Buprenorphine Transdermal Patches, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Buprenorphine Transdermal Patches sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Buprenorphine Transdermal Patches market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Buprenorphine Transdermal Patches sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Grunenthal, PurduePharma and Luye Pharma, etc.

Market Segmentation
By Company
    Grunenthal
    PurduePharma
    Luye Pharma

Segment by Type
    5mcg/h
    7.5mcg/h
    10mcg/h
    15 mcg/h
    20 mcg/h

Segment by Application
    Relieve Cancer Pain
    Other

Segment by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Buprenorphine Transdermal Patches in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Buprenorphine Transdermal Patches manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Buprenorphine Transdermal Patches sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
    Table 1. Global Buprenorphine Transdermal Patches Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of 5mcg/h
    Table 3. Major Manufacturers of 7.5mcg/h
    Table 4. Major Manufacturers of 10mcg/h
    Table 5. Major Manufacturers of 15 mcg/h
    Table 6. Major Manufacturers of 20 mcg/h
    Table 7. Global Buprenorphine Transdermal Patches Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 8. Global Buprenorphine Transdermal Patches Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 9. Global Buprenorphine Transdermal Patches Revenue by Region (2019-2024) & (US$ Million)
    Table 10. Global Buprenorphine Transdermal Patches Revenue by Region (2025-2030) & (US$ Million)
    Table 11. Global Buprenorphine Transdermal Patches Revenue Market Share by Region (2019-2024)
    Table 12. Global Buprenorphine Transdermal Patches Revenue Market Share by Region (2025-2030)
    Table 13. Global Buprenorphine Transdermal Patches Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Buprenorphine Transdermal Patches Sales by Region (2019-2024) & (K Units)
    Table 15. Global Buprenorphine Transdermal Patches Sales by Region (2025-2030) & (K Units)
    Table 16. Global Buprenorphine Transdermal Patches Sales Market Share by Region (2019-2024)
    Table 17. Global Buprenorphine Transdermal Patches Sales Market Share by Region (2025-2030)
    Table 18. Global Buprenorphine Transdermal Patches Sales by Manufacturers (2019-2024) & (K Units)
    Table 19. Global Buprenorphine Transdermal Patches Sales Share by Manufacturers (2019-2024)
    Table 20. Global Buprenorphine Transdermal Patches Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 21. Global Buprenorphine Transdermal Patches Revenue Share by Manufacturers (2019-2024)
    Table 22. Global Key Players of Buprenorphine Transdermal Patches, Industry Ranking, 2022 VS 2023 VS 2024
    Table 23. Buprenorphine Transdermal Patches Price by Manufacturers 2019-2024 (US$/Unit)
    Table 24. Global Buprenorphine Transdermal Patches Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 25. Global Buprenorphine Transdermal Patches by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Buprenorphine Transdermal Patches as of 2023)
    Table 26. Global Key Manufacturers of Buprenorphine Transdermal Patches, Manufacturing Base Distribution and Headquarters
    Table 27. Global Key Manufacturers of Buprenorphine Transdermal Patches, Product Offered and Application
    Table 28. Global Key Manufacturers of Buprenorphine Transdermal Patches, Date of Enter into This Industry
    Table 29. Mergers & Acquisitions, Expansion Plans
    Table 30. Global Buprenorphine Transdermal Patches Sales by Type (2019-2024) & (K Units)
    Table 31. Global Buprenorphine Transdermal Patches Sales by Type (2025-2030) & (K Units)
    Table 32. Global Buprenorphine Transdermal Patches Sales Share by Type (2019-2024)
    Table 33. Global Buprenorphine Transdermal Patches Sales Share by Type (2025-2030)
    Table 34. Global Buprenorphine Transdermal Patches Revenue by Type (2019-2024) & (US$ Million)
    Table 35. Global Buprenorphine Transdermal Patches Revenue by Type (2025-2030) & (US$ Million)
    Table 36. Global Buprenorphine Transdermal Patches Revenue Share by Type (2019-2024)
    Table 37. Global Buprenorphine Transdermal Patches Revenue Share by Type (2025-2030)
    Table 38. Buprenorphine Transdermal Patches Price by Type (2019-2024) & (US$/Unit)
    Table 39. Global Buprenorphine Transdermal Patches Price Forecast by Type (2025-2030) & (US$/Unit)
    Table 40. Global Buprenorphine Transdermal Patches Sales by Application (2019-2024) & (K Units)
    Table 41. Global Buprenorphine Transdermal Patches Sales by Application (2025-2030) & (K Units)
    Table 42. Global Buprenorphine Transdermal Patches Sales Share by Application (2019-2024)
    Table 43. Global Buprenorphine Transdermal Patches Sales Share by Application (2025-2030)
    Table 44. Global Buprenorphine Transdermal Patches Revenue by Application (2019-2024) & (US$ Million)
    Table 45. Global Buprenorphine Transdermal Patches Revenue by Application (2025-2030) & (US$ Million)
    Table 46. Global Buprenorphine Transdermal Patches Revenue Share by Application (2019-2024)
    Table 47. Global Buprenorphine Transdermal Patches Revenue Share by Application (2025-2030)
    Table 48. Buprenorphine Transdermal Patches Price by Application (2019-2024) & (US$/Unit)
    Table 49. Global Buprenorphine Transdermal Patches Price Forecast by Application (2025-2030) & (US$/Unit)
    Table 50. US & Canada Buprenorphine Transdermal Patches Sales by Type (2019-2024) & (K Units)
    Table 51. US & Canada Buprenorphine Transdermal Patches Sales by Type (2025-2030) & (K Units)
    Table 52. US & Canada Buprenorphine Transdermal Patches Revenue by Type (2019-2024) & (US$ Million)
    Table 53. US & Canada Buprenorphine Transdermal Patches Revenue by Type (2025-2030) & (US$ Million)
    Table 54. US & Canada Buprenorphine Transdermal Patches Sales by Application (2019-2024) & (K Units)
    Table 55. US & Canada Buprenorphine Transdermal Patches Sales by Application (2025-2030) & (K Units)
    Table 56. US & Canada Buprenorphine Transdermal Patches Revenue by Application (2019-2024) & (US$ Million)
    Table 57. US & Canada Buprenorphine Transdermal Patches Revenue by Application (2025-2030) & (US$ Million)
    Table 58. US & Canada Buprenorphine Transdermal Patches Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 59. US & Canada Buprenorphine Transdermal Patches Revenue by Country (2019-2024) & (US$ Million)
    Table 60. US & Canada Buprenorphine Transdermal Patches Revenue by Country (2025-2030) & (US$ Million)
    Table 61. US & Canada Buprenorphine Transdermal Patches Sales by Country (2019-2024) & (K Units)
    Table 62. US & Canada Buprenorphine Transdermal Patches Sales by Country (2025-2030) & (K Units)
    Table 63. Europe Buprenorphine Transdermal Patches Sales by Type (2019-2024) & (K Units)
    Table 64. Europe Buprenorphine Transdermal Patches Sales by Type (2025-2030) & (K Units)
    Table 65. Europe Buprenorphine Transdermal Patches Revenue by Type (2019-2024) & (US$ Million)
    Table 66. Europe Buprenorphine Transdermal Patches Revenue by Type (2025-2030) & (US$ Million)
    Table 67. Europe Buprenorphine Transdermal Patches Sales by Application (2019-2024) & (K Units)
    Table 68. Europe Buprenorphine Transdermal Patches Sales by Application (2025-2030) & (K Units)
    Table 69. Europe Buprenorphine Transdermal Patches Revenue by Application (2019-2024) & (US$ Million)
    Table 70. Europe Buprenorphine Transdermal Patches Revenue by Application (2025-2030) & (US$ Million)
    Table 71. Europe Buprenorphine Transdermal Patches Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 72. Europe Buprenorphine Transdermal Patches Revenue by Country (2019-2024) & (US$ Million)
    Table 73. Europe Buprenorphine Transdermal Patches Revenue by Country (2025-2030) & (US$ Million)
    Table 74. Europe Buprenorphine Transdermal Patches Sales by Country (2019-2024) & (K Units)
    Table 75. Europe Buprenorphine Transdermal Patches Sales by Country (2025-2030) & (K Units)
    Table 76. China Buprenorphine Transdermal Patches Sales by Type (2019-2024) & (K Units)
    Table 77. China Buprenorphine Transdermal Patches Sales by Type (2025-2030) & (K Units)
    Table 78. China Buprenorphine Transdermal Patches Revenue by Type (2019-2024) & (US$ Million)
    Table 79. China Buprenorphine Transdermal Patches Revenue by Type (2025-2030) & (US$ Million)
    Table 80. China Buprenorphine Transdermal Patches Sales by Application (2019-2024) & (K Units)
    Table 81. China Buprenorphine Transdermal Patches Sales by Application (2025-2030) & (K Units)
    Table 82. China Buprenorphine Transdermal Patches Revenue by Application (2019-2024) & (US$ Million)
    Table 83. China Buprenorphine Transdermal Patches Revenue by Application (2025-2030) & (US$ Million)
    Table 84. Asia Buprenorphine Transdermal Patches Sales by Type (2019-2024) & (K Units)
    Table 85. Asia Buprenorphine Transdermal Patches Sales by Type (2025-2030) & (K Units)
    Table 86. Asia Buprenorphine Transdermal Patches Revenue by Type (2019-2024) & (US$ Million)
    Table 87. Asia Buprenorphine Transdermal Patches Revenue by Type (2025-2030) & (US$ Million)
    Table 88. Asia Buprenorphine Transdermal Patches Sales by Application (2019-2024) & (K Units)
    Table 89. Asia Buprenorphine Transdermal Patches Sales by Application (2025-2030) & (K Units)
    Table 90. Asia Buprenorphine Transdermal Patches Revenue by Application (2019-2024) & (US$ Million)
    Table 91. Asia Buprenorphine Transdermal Patches Revenue by Application (2025-2030) & (US$ Million)
    Table 92. Asia Buprenorphine Transdermal Patches Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 93. Asia Buprenorphine Transdermal Patches Revenue by Region (2019-2024) & (US$ Million)
    Table 94. Asia Buprenorphine Transdermal Patches Revenue by Region (2025-2030) & (US$ Million)
    Table 95. Asia Buprenorphine Transdermal Patches Sales by Region (2019-2024) & (K Units)
    Table 96. Asia Buprenorphine Transdermal Patches Sales by Region (2025-2030) & (K Units)
    Table 97. Middle East, Africa and Latin America Buprenorphine Transdermal Patches Sales by Type (2019-2024) & (K Units)
    Table 98. Middle East, Africa and Latin America Buprenorphine Transdermal Patches Sales by Type (2025-2030) & (K Units)
    Table 99. Middle East, Africa and Latin America Buprenorphine Transdermal Patches Revenue by Type (2019-2024) & (US$ Million)
    Table 100. Middle East, Africa and Latin America Buprenorphine Transdermal Patches Revenue by Type (2025-2030) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Buprenorphine Transdermal Patches Sales by Application (2019-2024) & (K Units)
    Table 102. Middle East, Africa and Latin America Buprenorphine Transdermal Patches Sales by Application (2025-2030) & (K Units)
    Table 103. Middle East, Africa and Latin America Buprenorphine Transdermal Patches Revenue by Application (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Buprenorphine Transdermal Patches Revenue by Application (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Buprenorphine Transdermal Patches Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 106. Middle East, Africa and Latin America Buprenorphine Transdermal Patches Revenue by Country (2019-2024) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Buprenorphine Transdermal Patches Revenue by Country (2025-2030) & (US$ Million)
    Table 108. Middle East, Africa and Latin America Buprenorphine Transdermal Patches Sales by Country (2019-2024) & (K Units)
    Table 109. Middle East, Africa and Latin America Buprenorphine Transdermal Patches Sales by Country (2025-2030) & (K Units)
    Table 110. Grunenthal Company Information
    Table 111. Grunenthal Description and Major Businesses
    Table 112. Grunenthal Buprenorphine Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Grunenthal Buprenorphine Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Grunenthal Recent Developments
    Table 115. PurduePharma Company Information
    Table 116. PurduePharma Description and Major Businesses
    Table 117. PurduePharma Buprenorphine Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. PurduePharma Buprenorphine Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. PurduePharma Recent Developments
    Table 120. Luye Pharma Company Information
    Table 121. Luye Pharma Description and Major Businesses
    Table 122. Luye Pharma Buprenorphine Transdermal Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Luye Pharma Buprenorphine Transdermal Patches Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Luye Pharma Recent Developments
    Table 125. Key Raw Materials Lists
    Table 126. Raw Materials Key Suppliers Lists
    Table 127. Buprenorphine Transdermal Patches Distributors List
    Table 128. Buprenorphine Transdermal Patches Customers List
    Table 129. Buprenorphine Transdermal Patches Market Trends
    Table 130. Buprenorphine Transdermal Patches Market Drivers
    Table 131. Buprenorphine Transdermal Patches Market Challenges
    Table 132. Buprenorphine Transdermal Patches Market Restraints
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Buprenorphine Transdermal Patches Product Picture
    Figure 2. Global Buprenorphine Transdermal Patches Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Buprenorphine Transdermal Patches Market Share by Type in 2023 & 2030
    Figure 4. 5mcg/h Product Picture
    Figure 5. 7.5mcg/h Product Picture
    Figure 6. 10mcg/h Product Picture
    Figure 7. 15 mcg/h Product Picture
    Figure 8. 20 mcg/h Product Picture
    Figure 9. Global Buprenorphine Transdermal Patches Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 10. Global Buprenorphine Transdermal Patches Market Share by Application in 2023 & 2030
    Figure 11. Relieve Cancer Pain
    Figure 12. Other
    Figure 13. Buprenorphine Transdermal Patches Report Years Considered
    Figure 14. Global Buprenorphine Transdermal Patches Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Buprenorphine Transdermal Patches Revenue 2019-2030 (US$ Million)
    Figure 16. Global Buprenorphine Transdermal Patches Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 17. Global Buprenorphine Transdermal Patches Revenue Market Share by Region (2019-2030)
    Figure 18. Global Buprenorphine Transdermal Patches Sales 2019-2030 ((K Units)
    Figure 19. Global Buprenorphine Transdermal Patches Sales Market Share by Region (2019-2030)
    Figure 20. US & Canada Buprenorphine Transdermal Patches Sales YoY (2019-2030) & (K Units)
    Figure 21. US & Canada Buprenorphine Transdermal Patches Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. Europe Buprenorphine Transdermal Patches Sales YoY (2019-2030) & (K Units)
    Figure 23. Europe Buprenorphine Transdermal Patches Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. China Buprenorphine Transdermal Patches Sales YoY (2019-2030) & (K Units)
    Figure 25. China Buprenorphine Transdermal Patches Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Asia (excluding China) Buprenorphine Transdermal Patches Sales YoY (2019-2030) & (K Units)
    Figure 27. Asia (excluding China) Buprenorphine Transdermal Patches Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. Middle East, Africa and Latin America Buprenorphine Transdermal Patches Sales YoY (2019-2030) & (K Units)
    Figure 29. Middle East, Africa and Latin America Buprenorphine Transdermal Patches Revenue YoY (2019-2030) & (US$ Million)
    Figure 30. The Buprenorphine Transdermal Patches Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 31. The Top 5 and 10 Largest Manufacturers of Buprenorphine Transdermal Patches in the World: Market Share by Buprenorphine Transdermal Patches Revenue in 2023
    Figure 32. Global Buprenorphine Transdermal Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 33. Global Buprenorphine Transdermal Patches Sales Market Share by Type (2019-2030)
    Figure 34. Global Buprenorphine Transdermal Patches Revenue Market Share by Type (2019-2030)
    Figure 35. Global Buprenorphine Transdermal Patches Sales Market Share by Application (2019-2030)
    Figure 36. Global Buprenorphine Transdermal Patches Revenue Market Share by Application (2019-2030)
    Figure 37. US & Canada Buprenorphine Transdermal Patches Sales Market Share by Type (2019-2030)
    Figure 38. US & Canada Buprenorphine Transdermal Patches Revenue Market Share by Type (2019-2030)
    Figure 39. US & Canada Buprenorphine Transdermal Patches Sales Market Share by Application (2019-2030)
    Figure 40. US & Canada Buprenorphine Transdermal Patches Revenue Market Share by Application (2019-2030)
    Figure 41. US & Canada Buprenorphine Transdermal Patches Revenue Share by Country (2019-2030)
    Figure 42. US & Canada Buprenorphine Transdermal Patches Sales Share by Country (2019-2030)
    Figure 43. U.S. Buprenorphine Transdermal Patches Revenue (2019-2030) & (US$ Million)
    Figure 44. Canada Buprenorphine Transdermal Patches Revenue (2019-2030) & (US$ Million)
    Figure 45. Europe Buprenorphine Transdermal Patches Sales Market Share by Type (2019-2030)
    Figure 46. Europe Buprenorphine Transdermal Patches Revenue Market Share by Type (2019-2030)
    Figure 47. Europe Buprenorphine Transdermal Patches Sales Market Share by Application (2019-2030)
    Figure 48. Europe Buprenorphine Transdermal Patches Revenue Market Share by Application (2019-2030)
    Figure 49. Europe Buprenorphine Transdermal Patches Revenue Share by Country (2019-2030)
    Figure 50. Europe Buprenorphine Transdermal Patches Sales Share by Country (2019-2030)
    Figure 51. Germany Buprenorphine Transdermal Patches Revenue (2019-2030) & (US$ Million)
    Figure 52. France Buprenorphine Transdermal Patches Revenue (2019-2030) & (US$ Million)
    Figure 53. U.K. Buprenorphine Transdermal Patches Revenue (2019-2030) & (US$ Million)
    Figure 54. Italy Buprenorphine Transdermal Patches Revenue (2019-2030) & (US$ Million)
    Figure 55. Russia Buprenorphine Transdermal Patches Revenue (2019-2030) & (US$ Million)
    Figure 56. China Buprenorphine Transdermal Patches Sales Market Share by Type (2019-2030)
    Figure 57. China Buprenorphine Transdermal Patches Revenue Market Share by Type (2019-2030)
    Figure 58. China Buprenorphine Transdermal Patches Sales Market Share by Application (2019-2030)
    Figure 59. China Buprenorphine Transdermal Patches Revenue Market Share by Application (2019-2030)
    Figure 60. Asia Buprenorphine Transdermal Patches Sales Market Share by Type (2019-2030)
    Figure 61. Asia Buprenorphine Transdermal Patches Revenue Market Share by Type (2019-2030)
    Figure 62. Asia Buprenorphine Transdermal Patches Sales Market Share by Application (2019-2030)
    Figure 63. Asia Buprenorphine Transdermal Patches Revenue Market Share by Application (2019-2030)
    Figure 64. Asia Buprenorphine Transdermal Patches Revenue Share by Region (2019-2030)
    Figure 65. Asia Buprenorphine Transdermal Patches Sales Share by Region (2019-2030)
    Figure 66. Japan Buprenorphine Transdermal Patches Revenue (2019-2030) & (US$ Million)
    Figure 67. South Korea Buprenorphine Transdermal Patches Revenue (2019-2030) & (US$ Million)
    Figure 68. China Taiwan Buprenorphine Transdermal Patches Revenue (2019-2030) & (US$ Million)
    Figure 69. Southeast Asia Buprenorphine Transdermal Patches Revenue (2019-2030) & (US$ Million)
    Figure 70. India Buprenorphine Transdermal Patches Revenue (2019-2030) & (US$ Million)
    Figure 71. Middle East, Africa and Latin America Buprenorphine Transdermal Patches Sales Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Buprenorphine Transdermal Patches Revenue Market Share by Type (2019-2030)
    Figure 73. Middle East, Africa and Latin America Buprenorphine Transdermal Patches Sales Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Buprenorphine Transdermal Patches Revenue Market Share by Application (2019-2030)
    Figure 75. Middle East, Africa and Latin America Buprenorphine Transdermal Patches Revenue Share by Country (2019-2030)
    Figure 76. Middle East, Africa and Latin America Buprenorphine Transdermal Patches Sales Share by Country (2019-2030)
    Figure 77. Brazil Buprenorphine Transdermal Patches Revenue (2019-2030) & (US$ Million)
    Figure 78. Mexico Buprenorphine Transdermal Patches Revenue (2019-2030) & (US$ Million)
    Figure 79. Turkey Buprenorphine Transdermal Patches Revenue (2019-2030) & (US$ Million)
    Figure 80. Israel Buprenorphine Transdermal Patches Revenue (2019-2030) & (US$ Million)
    Figure 81. GCC Countries Buprenorphine Transdermal Patches Revenue (2019-2030) & (US$ Million)
    Figure 82. Buprenorphine Transdermal Patches Value Chain
    Figure 83. Buprenorphine Transdermal Patches Production Process
    Figure 84. Channels of Distribution
    Figure 85. Distributors Profiles
    Figure 86. Bottom-up and Top-down Approaches for This Report
    Figure 87. Data Triangulation
    Figure 88. Key Executives Interviewed